{"count":2329,"next":"https://api-test.medunigraz.at/v1/research/project/?format=json&limit=20&offset=1800&ordering=-begin_effective","previous":"https://api-test.medunigraz.at/v1/research/project/?format=json&limit=20&offset=1760&ordering=-begin_effective","results":[{"id":2118,"title":{"de":"Antitumor-Aktivität bioaktiver Wirkstoffe in chemoresistenten Tumoren: Apoptose in Medullären Schilddrüsencarcinomen","en":"Antitumor-Aktivität bioaktiver Wirkstoffe in chemoresistenten Tumoren: Apoptose in Medullären Schilddrüsencarcinomen"},"short":"APOPTOSE_MEDULL_SCHILDDRÜSCARC","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2009-06-01T02:00:00+02:00","begin_effective":"2011-03-01T01:00:00+01:00","end_planned":"2009-11-30T01:00:00+01:00","end_effective":"2011-09-30T02:00:00+02:00","assignment":"2010-02-12T11:41:30+01:00","program":null,"subprogram":null,"organization":14014,"category":10,"type":10,"partner_function":4,"manager":null,"contact":null,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[457],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2386,"title":{"de":"Europäisches Forschungs-Ethikkommissions-Netzwerk","en":"European Research Ethics Committees’ Network"},"short":"EURECNET","url":"http://www.eurecnet.org/index.html","abstract":{"de":null,"en":"EURECNET is a network that brings together national REC associations, networks or comparable initiatives but also other bodies relevant in the field of research involving human participants like National Ethics Councils and the European Commission's ethical review system. Such a network forms the infrastructural basis to promote awareness of specific working practices of RECs across Europe, to enhance the shared knowledge base of European RECs, to support coherent reviews and opinions and to meet new challenges and emerging ethical issues. The central objective of EURECNET as a Coordinating Action is to foster the already existing network of European REC networks (in short 'EUREC').\r\n\r\nIn particular, the contribution of EURECNET aims at five different levels:\r\n- fostering a sustainable infrastructure for European RECs (including a statute and a secretariat) to promote exchange and cooperation and to allow for international cooperation;\r\n- gathering information on RECs in Europe to build a basis for mutual exchange - collecting and evaluating training materials for REC members to enhance the quality of review;\r\n- conducting capacity building to facilitate the development of national REC networks (as future partners of EUREC);\r\n- identifying emerging ethical issues to develop common solutions for challenges posed by new technologies and scientific methodologies."},"begin_planned":"2009-07-01T02:00:00+02:00","begin_effective":"2011-03-01T01:00:00+01:00","end_planned":"2012-06-30T02:00:00+02:00","end_effective":"2014-08-31T02:00:00+02:00","assignment":"2011-01-31T12:01:32+01:00","program":24,"subprogram":"Area: 5.1.1.2 Research on Ethics in science and technology\r\nTopic: SiS-2009-1.1.2.2 Networking and capacity-building activities to support ethics committees:","organization":14038,"category":10,"type":10,"partner_function":2,"manager":51627,"contact":51627,"status":2,"research":5,"grant":10,"event":null,"study":null,"language":null,"funders":[10],"funder_projectcode":"244519","ethics_committee":null,"edudract_number":null,"persons":["2386-51627-10"]},{"id":2406,"title":{"de":"Adipokine Visfatin und Chemerin im Kindes- und Jugendalter","en":"The adipokines visfatin and chemerin in childhood and adolescence"},"short":"ADIPOKINE VISFATIN CHEMERIN","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-10-01T02:00:00+02:00","begin_effective":"2011-03-01T01:00:00+01:00","end_planned":"2011-10-01T02:00:00+02:00","end_effective":"2011-12-30T01:00:00+01:00","assignment":"2011-02-15T12:46:08+01:00","program":null,"subprogram":null,"organization":14091,"category":10,"type":10,"partner_function":4,"manager":null,"contact":null,"status":2,"research":4,"grant":10,"event":null,"study":null,"language":null,"funders":[135],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2414,"title":{"de":"Rolle des enterischen Nervensystems (ENS) auf die Chemotaxis von Leukozyten in der Entzuendung","en":"Chemoattraction of leukocytes by the enteric nervous system (ENS) during inflammation"},"short":"CHEMOATTR_LEUKOCYTES_ENS","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-11-01T01:00:00+01:00","begin_effective":"2011-03-01T01:00:00+01:00","end_planned":"2011-10-31T01:00:00+01:00","end_effective":"2012-02-28T01:00:00+01:00","assignment":"2011-02-17T09:32:46+01:00","program":null,"subprogram":null,"organization":14022,"category":10,"type":10,"partner_function":4,"manager":56687,"contact":56687,"status":2,"research":3,"grant":10,"event":null,"study":null,"language":null,"funders":[530],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2414-56687-10"]},{"id":2366,"title":{"de":"\"Advanced\" EEG in der Vorhersage des Verlaufs der Alzheimerdemenz\"","en":"\"Advanced\" EEG in the prediction of the clinical course of Alzheimer dementia"},"short":"EEG und Alzheimer","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2013-12-31T01:00:00+01:00","end_effective":"2015-01-31T01:00:00+01:00","assignment":"2010-12-21T10:16:33+01:00","program":60,"subprogram":null,"organization":14051,"category":10,"type":10,"partner_function":3,"manager":null,"contact":null,"status":2,"research":2,"grant":10,"event":null,"study":null,"language":null,"funders":[416],"funder_projectcode":"827462","ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2458,"title":{"de":"European Sequencing and Genotyping Infrastructure","en":"European Sequencing and Genotyping Infrastructure"},"short":"ESGI","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-06-01T02:00:00+02:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2014-05-31T02:00:00+02:00","end_effective":"2015-07-31T02:00:00+02:00","assignment":"2011-03-31T13:20:58+02:00","program":24,"subprogram":"Infrastructures","organization":14020,"category":10,"type":10,"partner_function":2,"manager":51663,"contact":51663,"status":2,"research":2,"grant":10,"event":null,"study":null,"language":null,"funders":[10],"funder_projectcode":"262055","ethics_committee":null,"edudract_number":null,"persons":["2458-51663-10"]},{"id":2382,"title":{"de":"INTEROZEPTION KARDIALER AKTIVITÄT, STRESS-REAKTIVITÄT UND ATOPISCHE DERMATITIS","en":"CARDIAC AWARENESS, STRESS REACTIVITY  AND ATOPIC DERMATITIS"},"short":"CARDIAC AWARE STRESS REACT ATOPIC DERMAT","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-02-01T01:00:00+01:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2012-02-01T01:00:00+01:00","end_effective":"2012-02-01T01:00:00+01:00","assignment":"2011-01-19T15:03:26+01:00","program":null,"subprogram":null,"organization":29447,"category":10,"type":10,"partner_function":4,"manager":60040,"contact":60040,"status":2,"research":2,"grant":10,"event":null,"study":null,"language":null,"funders":[135],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2382-60040-10"]},{"id":2434,"title":{"de":"Darmverlängerung durch mechnische Dehnung (MESI)","en":"MESI: Mechanical Elongation of Small Intestine"},"short":"MESI","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-09-01T02:00:00+02:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2012-08-31T02:00:00+02:00","end_effective":"2012-12-30T01:00:00+01:00","assignment":"2011-03-02T14:14:05+01:00","program":null,"subprogram":"Land Steiermark A3","organization":14049,"category":10,"type":10,"partner_function":4,"manager":50052,"contact":50052,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[135],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2434-50052-10"]},{"id":2379,"title":{"de":"Die Bedeutung der Th9-Achse bei Psoriasis ","en":"The role of Th9 in psoriasis"},"short":"TH9_PSORIASIS","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-02-01T01:00:00+01:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2012-01-31T01:00:00+01:00","end_effective":"2012-01-31T01:00:00+01:00","assignment":"2011-01-17T10:12:57+01:00","program":null,"subprogram":null,"organization":14047,"category":10,"type":10,"partner_function":4,"manager":51618,"contact":51618,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[1161],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2379-51618-10"]},{"id":2418,"title":{"de":"Uveales Melanom: Bio-psycho-soziale Aspekte","en":"Uveal melanoma: Bio-psyco-social aspects "},"short":"UVEAL MELANOMA_BIO_PSYCHO_SOCIAL_ASPECTS","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-06-01T02:00:00+02:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2011-05-31T02:00:00+02:00","end_effective":"2012-01-31T01:00:00+01:00","assignment":"2011-02-17T11:06:13+01:00","program":null,"subprogram":null,"organization":14043,"category":10,"type":10,"partner_function":4,"manager":61522,"contact":61522,"status":2,"research":2,"grant":10,"event":null,"study":null,"language":null,"funders":[938],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2418-61522-10"]},{"id":2154,"title":{"de":"Contribution of cell-cell contacts and cross-talk to cell conversion into cardiomyocytes ","en":"Contribution of cell-cell contacts and cross-talk to cell conversion into cardiomyocytes "},"short":"CARDIOMYOCYTES","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-01-01T01:00:00+01:00","begin_effective":"2011-02-01T01:00:00+01:00","end_planned":"2013-12-31T01:00:00+01:00","end_effective":"2014-01-31T01:00:00+01:00","assignment":"2010-03-04T15:03:51+01:00","program":72,"subprogram":null,"organization":14073,"category":10,"type":10,"partner_function":4,"manager":null,"contact":null,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[9],"funder_projectcode":"P22466","ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2391,"title":{"de":"Einfluss der Knochenentnahmetechnik auf die Osteoblastenaktivität","en":"Effect of Bone Harvesting Methods to the Osteoblast activity"},"short":"KNOCHENENTNAHME_OSTEOBLAST","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2009-04-01T02:00:00+02:00","begin_effective":"2011-01-26T01:00:00+01:00","end_planned":"2010-10-01T02:00:00+02:00","end_effective":"2017-12-31T01:00:00+01:00","assignment":"2011-02-04T09:47:14+01:00","program":null,"subprogram":null,"organization":14057,"category":10,"type":10,"partner_function":4,"manager":null,"contact":null,"status":2,"research":4,"grant":10,"event":null,"study":null,"language":null,"funders":[135],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2395,"title":{"de":"Mechanische Änderungen von Musculus Triceps Surae im Laufe des  Skelettwachstums - funktionelle Beurteilung von Kontrakturen bei Kindern mit spastischer diplegischer Zerebralparese","en":"Mechanical changes of triceps surae muscle with skeletal growth - functional evaluation of contractures in children with spastic diplegic cerebral palsy"},"short":"MECHANICAL CHANGES SKELETAL GROWTH","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2012-12-31T01:00:00+01:00","end_effective":"2013-02-28T01:00:00+01:00","assignment":"2011-02-04T12:14:35+01:00","program":null,"subprogram":"Österreichische Akademie der Wissenschaften -\r\nAustrian Programme for Advanced Research and Technology ","organization":14049,"category":10,"type":10,"partner_function":4,"manager":65038,"contact":65038,"status":2,"research":5,"grant":10,"event":null,"study":null,"language":null,"funders":[15],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2395-65038-10"]},{"id":2336,"title":{"de":"Multiskalen-Modellierung von Kalzium-vermittelter getriggerter Aktivität im Herzen","en":"Multi-scale Modeling of Calcium Mediated Triggered Activity in the Heart"},"short":"Calcium_Mediated_Heart_Activity","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-12-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2014-12-01T01:00:00+01:00","end_effective":"2015-06-30T02:00:00+02:00","assignment":"2010-11-10T12:06:47+01:00","program":null,"subprogram":null,"organization":14011,"category":10,"type":10,"partner_function":2,"manager":50966,"contact":50966,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[724],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2336-50966-10"]},{"id":3226,"title":{"de":"Von Hypertrophie zur Herzinsuffizienz-die Rolle des spontanen SR Ca2+ Lecks","en":"From hypertrophy to heart failure-the role of spontaneous SR Ca2+ leak"},"short":"MUG Start","url":null,"abstract":{"de":null,"en":"Heart failure (HF) is a leading cause of death in the developed countries. Despite considerable progress in the past decade in our understanding of cellular and molecular mechanisms involved in the progression of HF, therapeutic agents that specifically target the underlying cellular defects remain rare and ineffective. In HF, intracellular Ca2+ homeostasis is altered and increased cytosolic Ca2+ has been proposed as a potential activator of hypertrophic signalling cascades, ultimately culminating in overt HF phenotype. Recent studies pointed out that increased spontaneous Ca2+ release (Ca2+ leak) from the sarcoplasmic reticulum (SR) Ca2+ release channel (ryanodine receptor, RyR2) due to defective regulation of the RyR2 occurs during HF and causes contractile dysfunction and development of arrhythmias. However, it remains controversial whether increased SR Ca2+ leak is an epiphenomenon accompanying HF only or a pathophysiologically relevant process contributing to accelerated decompensation from hypertrophy to HF.\r\nIn the proposed project, we will pursue the hypothesis, that an increased spontaneous SR Ca2+ leak per se is causally involved in accelerated decompensation from cardiac hypertrophy to HF. We will take advantage of the minimally invasive transverse aortic constriction (TAC) as a pressure overload model for HF, and apply it to a mouse model with an inherited SR Ca2+ leak (knock-in RyR2R4496C+/- human mutation). Our preliminary results show strikingly increased hypertrophy and accelerated transition from hypertrophy to HF in RyR2R4496C+/- hearts after TAC, confirming our initial hypothesis. In the current project, we aim to identify the mechanism(s) of the transition from hypertrophy to overt HF. We will investigate, whether congenital SR Ca2+ leak in RyR2R4496C+/- cardiomyocytes is increased after TAC and, subsequently, leads to alterations in expression and/or phosphorylation pattern of Ca2+ regulatory proteins and transcription factors involved in Ca2+-dependent hypertrophic signalling pathways. Using in vivo ECG recordings, we will further determine the cause for premature cardiac death in RyR2R4496C+/--TAC mice. Additionally, rescue experiments will reveal, whether a putative RyR2 stabilizer (JTV-519) effectively decelerates the HF progression. \r\nWe anticipate that these results will help to define a new role for SR Ca2+ release in the transition from cardiac hypertrophy to HF. Since abnormal RyR2 Ca2+ release is regarded as the underlying mechanism for contractile dysfunction and arrhythmias, this project may contribute to the identification of novel molecular therapeutic targets in HF and thus, possibly improve clinical outcome in HF patients in the future.\r\n"},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2013-12-31T01:00:00+01:00","end_effective":"2013-12-31T01:00:00+01:00","assignment":"2013-04-02T15:52:03+02:00","program":null,"subprogram":null,"organization":14083,"category":10,"type":10,"partner_function":4,"manager":60041,"contact":null,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[894],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["3226-60041-10"]},{"id":1962,"title":{"de":"Charakterisierung der Splicevarianten des GIRK1 Gens aus Brustkrebszelllinien","en":"Charakterisierung der Splicevarianten des GIRK1 Gens aus Brustkrebszelllinien"},"short":"Splicevarianten des GIRK1","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2009-07-01T02:00:00+02:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2009-12-31T01:00:00+01:00","end_effective":"2011-06-30T02:00:00+02:00","assignment":"2009-10-29T15:34:59+01:00","program":null,"subprogram":"Land Steiermark Projekt über 5.000,- Euro","organization":14011,"category":10,"type":10,"partner_function":4,"manager":null,"contact":null,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[135],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":[]},{"id":2359,"title":{"de":"Hochauflösende Analyse zirkulierender Tumorzellen beim Mammakarzinom","en":"High-resolution analysis of circulating tumor cells from patients with breast cancer"},"short":"CIRCULATING TUMOR CELLS","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2012-12-31T01:00:00+01:00","end_effective":"2012-12-31T01:00:00+01:00","assignment":"2010-12-15T13:15:03+01:00","program":79,"subprogram":null,"organization":14021,"category":10,"type":10,"partner_function":4,"manager":57423,"contact":57423,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[12],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2359-57423-10"]},{"id":2365,"title":{"de":"Plasmakonzentration und genetische Polymorphismen von PCSK9 in Patienten mit koronarer Herzkrankheit","en":"Plasma concentration and polymorphisms of PCSK9 in patients with coronary artery disease "},"short":"PCSK9","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2012-01-31T01:00:00+01:00","end_effective":"2012-01-31T01:00:00+01:00","assignment":"2010-12-20T12:47:35+01:00","program":79,"subprogram":null,"organization":14028,"category":10,"type":10,"partner_function":4,"manager":50886,"contact":50886,"status":2,"research":4,"grant":10,"event":null,"study":null,"language":null,"funders":[12],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2365-50886-10"]},{"id":2363,"title":{"de":"Detektion der BRAF V600E Mutation in Lentigo Maligna Melanoma","en":"Detection of the BRAF V600E mutation in Lentigo Maligna Melanoma lesions"},"short":"BRAF V600E","url":null,"abstract":{"de":"Das maligne Melanom (MM) gilt als eine der aggressivsten Formen von Hautkrebs mit einer hohen\r\nSterblichkeitsrate und oftmals inadäquaten Therapiemöglichkeiten, insbesondere bei\r\nMetastasierung. Die Voraussetzungen für die Gabe neuer, vielversprechender Therapien sind die\r\npräzise Diagnose und das Wissen über den Mutationsstatus des Tumors.\r\nDie Diagnose der Lentigo maligna melanoma (LMM), einer Sonderform des MM, wird durch klinische\r\nund histopathologische Ähnlichkeiten mit pigmentierter aktinischer Keratose (in situ\r\nPlattenepithelkarzinom) und solarer Lentigo („einfacher Pigmentfleck“ oder „Altersfleck“) erschwert.\r\nÜber den genetischen Charakter von LMM (insbesondere hinsichtlich BRAF), aber auch solarer\r\nLentigo ist bisher nur wenig bekannt.\r\nDie BRAF V600E Mutation ist das am häufigsten detektierte onkologische Ereignis beim MM. In der\r\nvorliegenden Studie wird der Mutationsstatus von BRAF V600E in einem genau charakterisierten\r\nKollektiv aus FFPE LMM Gewebeproben analysiert. Dazu werden drei verschiedene, auf PCR\r\nbasierende, Methoden zur Mutationsanalyse optimiert und validiert. Die BRAF V600E\r\nMutationshäufigkeit wird in einem großem LMM Kollektiv bestimmt und ihre diagnostische und\r\nklinische Relevanz durch den Vergleich mit dem Mutationsstatus bei aktinischer Keratose und solarer\r\nLentigo evaluiert. Die Ergebnisse dieser Studie sollen zur Verbesserung der Diagnostik und\r\nDifferenzialdiagnostik und auch der Therapie des MM beitragen.","en":"Malignant melanoma (MM) is considered the most aggressive form of skin cancers with a high\r\nmortality and often ineffective treatment, especially for metastasis. Prerequisites for the application\r\nof new and promising therapies are the precise diagnosis and the knowledge of the mutational status\r\nof the tumor.\r\nDiagnosis of Lentigo maligna melanoma (LMM), a special form of MM, is complicated since\r\npigmented actinic keratosis (in situ squamous cell carcinoma) and solar lentigo (‘senile freckle’) can\r\nresemble LMM clinically and histopathologically. Only few data is available concerning the genetic\r\ncharacter of both LMM and solar lentigo (especially regarding BRAF).\r\nThe BRAF V600E mutation is the most frequent oncogenic event detected in MM. The study at hand\r\nwill analyze the BRAF V600E mutational status in a well characterized collective of FFPE LMM tissue\r\nsamples. For this purpose we will optimize and validate three different PCR based methods for\r\nmutational analysis. The incidence of the BRAF V600E mutation will be determined in a large LMM\r\ncollective and the diagnostic and clinical relevance of mutated BRAF will be evaluated by comparison\r\nwith that in pigmented actinic keratosis and solar lentigo. The results of this study should help to\r\nimprove the diagnostics means and contribute to advance therapy options of MM."},"begin_planned":"2011-01-01T01:00:00+01:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2012-06-30T02:00:00+02:00","end_effective":"2012-06-30T02:00:00+02:00","assignment":"2010-12-16T11:07:50+01:00","program":79,"subprogram":null,"organization":14085,"category":10,"type":10,"partner_function":null,"manager":50563,"contact":50563,"status":2,"research":2,"grant":10,"event":null,"study":null,"language":null,"funders":[12],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2363-50229-12","2363-50563-10","2363-51066-12","2363-51618-11"]},{"id":2339,"title":{"de":"Proteomic and microbial profiling of human cervico-vaginal fluid and saliva of pregnant women throughout gestation","en":"Proteomic and microbial profiling of human cervico-vaginal fluid and saliva of pregnant women throughout gestation"},"short":"PROTEOMIC PROFILING","url":null,"abstract":{"de":null,"en":null},"begin_planned":"2010-07-01T02:00:00+02:00","begin_effective":"2011-01-01T01:00:00+01:00","end_planned":"2011-12-31T01:00:00+01:00","end_effective":"2012-12-31T01:00:00+01:00","assignment":"2010-11-11T13:26:31+01:00","program":79,"subprogram":null,"organization":14064,"category":10,"type":10,"partner_function":4,"manager":51719,"contact":51719,"status":2,"research":1,"grant":10,"event":null,"study":null,"language":null,"funders":[12],"funder_projectcode":null,"ethics_committee":null,"edudract_number":null,"persons":["2339-51719-10"]}]}